The mechanisms by which cytokine signals prevent the activation and mitochondrial targeting of the proapoptotic protein Bax are unclear. Here we show, using primary human eosinophils, that in the absence of the prosurvival cytokines granulocytemacrophage colony-stimulating factor and interleukin 5, Bax spontaneously underwent activation and initiated mitochondrial disruption. Inhibition of Bax resulted in less eosinophil apoptosis, even in the absence of cytokines. Granulocyte-macrophage colony-stimulating factor induced activation of the kinase Erk1/2, which phosphorylated Thr167 of Bax; this facilitated new interaction of Bax with the prolyl isomerase Pin1. Blockade of Pin1 led to cleavage and mitochondrial translocation of Bax and caspase activation, regardless of the presence of cytokines. Our findings indicate that Pin1 is a key mediator of prosurvival signaling and is a regulator of Bax function.
Pulmonary eosinophilic inflammation is a defining feature of asthma. Within a few days of allergen challenge, airway eosinophils increase in number by 20-to 150-fold in humans and other animals 1, 2 . Depletion of eosinophils by systemic treatment of humans with steroids 3 or antibody to interleukin 5 (anti-IL-5) 4 or by genetic ablation in animal models 5 results in considerably attenuated submucosal matrix deposition, airway smooth muscle hyperplasia and, in some cases, airway hyper-responsiveness, which suggests a critical function for these cells in the pathology of the asthmatic lung.
Eosinophils, like neurons, are terminally differentiated, nondividing cells. Normally short lived (with an approximate half-life of 1.5 d), peripheral blood eosinophils show prolonged survival and activation after exposure to the antiapoptotic cytokines granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-5 and IL-3, which increase in the plasma and lungs after allergen challenge 6 . These cytokines exert overlapping effects on hematopoietic cells (such as neutrophils, eosinophils, monocytes and early progenitor cells) and share a common receptor b-subunit, which is important in the recruitment of intracellular adaptors, scaffolds and kinases 7 . Signaling from the receptors of these cytokines is initiated by recruitment and activation of the tyrosine kinases Jak2 and Lyn, which activate the transcription factor STAT pathway and the GTPase Ras-kinase Raf1-mitogen-activated protein kinase (MAPK) pathway, respectively 8, 9 . The Jak-STAT cascade induces transcription of the gene encoding the prosurvival protein Bcl-x L (ref. 10) , which can inhibit members of the proapoptotic Bcl-2 homology 3 domain-only Bcl-2 family (Bad, Bid and Bim) and prevent 'downstream' release of cytochrome c from mitochondria 11 . However, eosinophils have undetectable expression of antiapoptotic Bcl-2 and very low expression of Bcl-x L , even after treatment with cytokines 10 . Nevertheless, activation of the RasRaf1-MAPK cascade by prosurvival cytokines inhibits spontaneous eosinophil apoptosis by preventing mitochondrial translocation of Bax (A000364) 12 . Thus, it remains unknown how these signaling cascades regulate Bax function.
Pin1 (A002516), a peptidyl-prolyl isomerase (PPIase), is necessary for the production of GM-CSF as well as prosurvival signaling in cytokine-treated eosinophils 13 . Blockade of Pin1 antagonizes GM-CSF antiapoptotic signaling and rapidly induces activation of caspase-3 and subsequent cell death. Pin1 consists of an amino-terminal WW domain and a carboxy-terminal isomerase domain 14 . The WW domain binds to serine-proline (Ser-Pro) or threonine-proline (ThrPro) motifs often but not exclusively after phosphorylation mediated by proline-directed protein kinases such as cyclin-dependent kinases, glycogen synthase kinase 3, protein kinase C (PKC) and MAPKs 15 . Growing evidence suggests that Pin1 is important in the apoptosis of neurons and tumor cells 16 . Pin1 binds to phosphorylated Bcl-2 in cancer cells arrested in M phase 17 and to the tumor suppressor p53, which regulates expression of the gene encoding Bax 18 . Depletion of nuclear Pin1 accelerates neuronal cell death through excessive phosphorylation of Tau 17 or by enhancing the expression and function of BimEL 19 , a proapoptotic member of the Bcl-2 family. In the immune system, Bax and/or Bak are required for the induction of mitochondria-dependent apoptotic pathways. Cells lacking both Bax and Bak are resistant to cell death induced by a variety of stimuli, including DNA damage, growth factor withdrawal and nutrient starvation 20 . Bax and Bak can be antagonized by prosurvival cytokines 21 , but the mechanisms that mediate this antagonism are not well understood.
Using prosurvival factor-dependent primary human eosinophils, here we demonstrate that IL-5 or GM-CSF signaling triggered phosphorylation of Bax Thr167 mediated by the threonine-serine kinase Erk1/2. Phosphorylation at this Thr-Pro site enhanced Bax-Pin1 interactions and prevented exposure of the proapoptotic aminoterminal domain of Bax, as well as cleavage and mitochondrial targeting of Bax. Conversely, blockade of Pin1 accelerated the activation and mitochondrial localization of Bax, the activation of caspase-9 and caspase-3, and cell death. Our study indicates that Pin1 is a critical mediator of prosurvival signaling in eosinophils and clarifies how Bax is regulated during programmed eosinophil death.
RESULTS

Pin1 facilitates eosinophil survival
Blockade of Pin1 not only diminishes the production and prosurvival signaling of GM-CSF but also accelerates eosinophil death in vitro 13 and in vivo 2, 22 . IL-5, like GM-CSF, prolongs eosinophil survival 12 , possibly by a Bax-dependent mechanism. To identify these mechanisms, we left eosinophils untreated or incubated them with IL-5 or GM-CSF (Fig. 1) . Untreated eosinophils obtained from normal donors showed very low Pin1 isomerase activity 2 and showed activation of caspase-3 and caspase-9 and reproducibly underwent apoptosis (80-90%) within 3-4 d in vitro (Fig. 1a, c-e and data presented below). Treatment with IL-5 or GM-CSF resulted in considerably enhanced survival, suppression of caspase activation and more Pin1 activity (Fig. 1a, c-e and data presented below). Juglone, a selective and irreversible Pin1 inhibitor 23 , and a dominant negative Pin1 peptide composed of the WW domain tethered to a TAT penetratin tag and a histidine (His) tag (TAT-His-WW-Pin1), induced activation of caspase-9 and caspase-3 ( Fig. 1b-e ) and eosinophil apoptosis (Fig. 1a,e) in a dose-dependent way, even after treatment with IL-5 or GM-CSF. Even in the absence of IL-5 and GM-CSF, blockade of Pin1 accelerated eosinophil apoptosis (Fig. 1a ,e and data presented below). These effects were not present in the cells treated with a fusion of TAT and green fluorescent protein (TAT-His-GFP) or a fusion of TAT and a control peptide of the same amino acid composition and length as TAT-His-WW-Pin1 but with a 'scrambled' sequence (TAT-HisscWW). These results indicate that Pin1 is required for eosinophil survival induced by GM-CSF or IL-5 and suggest that Pin1 is a 'downstream' target of Jak2 or other kinases activated by cytokine signaling in eosinophils.
To address the relevance of Pin1 to asthma, we obtained eosinophils from donors by bronchoalveolar lavage (BAL) 2 d after segmental allergen challenge. Typically, more than 50% of cells in BAL fluid from these patients are activated eosinophils that show prolonged GM-CSFdependent survival ex vivo and more Pin1 isomerase activity 2, 13 . Despite the activated status of these eosinophils from BAL fluid, blockade of Pin1 ex vivo triggered cleavage of caspase-9 and caspase-3 without affecting Pin1 expression (Fig. 1f) . Caspase-8, which mediates death receptor-dependent apoptosis, was unaffected by Pin1 inhibitors (data not shown). Thus, Pin1 probably functions as a 'downstream' effector of GM-CSF and IL-5 signaling and regulates cell death through the intrinsic (mitochondria-and caspase-9-dependent) apoptotic pathway.
Pin1 prevents activation of Bax
The data presented above suggested that Pin1 regulates mitochondriadependent eosinophil apoptosis. Release of cytochrome c from mitochondria and subsequent cleavage of caspase-9 is influenced by the relative expression and activity of pro-and antiapoptotic proteins. GM-CSF and IL-5 can induce expression of the antiapoptotic proteins Bcl-x L , cIAP2 and survivin 10, 12 and can prevent translocation of the proapoptotic protein Bax to mitochondria 12 . Eosinophils also have variable expression of other antiapoptotic effectors (Mcl-1, PKC-a, Pim1, PI(3)K and MAPK 2, 24 ) and proapoptotic effectors (caspases) 25 , many of which contain Pin1-recognition sites (Ser-Pro or Thr-Pro).
To identify pro-and/or antiapoptotic proteins influenced by Pin1 activity, we treated eosinophils with GM-CSF or IL-5 before lysing them and immunoprecipitating the lysates with anti-Pin1. Caspase-8, cIAP2 and PKC-a reproducibly precipitated together with Pin1 in both resting and activated cells (Fig. 2a) , whereas Bax was associated with Pin1 only in eosinophils treated with GM-CSF or IL-5 (Fig. 2b) . We did not detect Bad or Bak by immunoblot analysis of cell lysates in any conditions. Treatment of cytokine-activated eosinophils with the Pin1 inhibitor juglone resulted in considerable attenuation of the interaction between Bax and Pin1 ( Fig. 2b) , which suggests that the PPIase activity of Pin1 is required for stable interaction between Pin1 and Bax.
To establish that activation of Bax was a prelude to death in this system, we incubated unstimulated eosinophils with the Bax inhibitor V5, a cell-permeable pentapeptide derived from the interaction domain of the DNA-repair protein Ku70 and Bax 26 . V5 blocks the mitochondrial targeting of active Bax 26 . Eosinophils treated with V5 showed significantly less but not complete resistance to apoptosis, but those incubated with a control peptide of identical length did not (Fig. 2c) . Notably, V5 also resulted in less but not complete elimination of cell death induced by TAT-His-WW-Pin1 (Fig. 2c) . The lack of complete 'rescue' probably reflected the heterogeneity of the freshly purified eosinophil populations used for these studies, which contained a spectrum of young, 'middle-aged' and old eosinophils, approximately 30% of which were at or beyond the point of mitochondrial disruption at the time of isolation (data not shown). Thus, it is expected that a large percentage of cells should be resistant to V5-mediated 'rescue' . These results collectively suggest that activation of Bax is a critical step leading to eosinophil apoptosis after cytokine withdrawal or inhibition of Pin1.
Given the dependence of apoptosis on Pin1 and Bax, we hypothesized that Pin1-mediated formation of isomers would prevent activation of Bax. To test our hypothesis, we exposed eosinophils to GM-CSF or IL-5 alone, Pin1 inhibitors alone, or both cytokines and inhibitors. We assessed the conformation of Bax with the antibody 6A7, which recognizes the amino-terminal activation domain of Bax 27 . Brief exposure (10 min) to GM-CSF or IL-5 resulted in more PPIase activity; treatment with juglone or TAT-His-WW-Pin1 resulted in less PPIase activity but did not alter Pin1 expression ( Fig. 2d and data not shown). Cytokine treatment also induced interaction between Pin1 and Bax; this interaction was also blocked by juglone (Fig. 2b) . In eosinophils treated for 10 min with either GM-CSF or IL-5, exposure of the 6A7 epitope was detectable but low ( Fig. 2e and data not shown). The small amount of activated Bax probably reflected the presence of a small percentage of aged eosinophils undergoing irreversible apoptosis despite cytokine treatment. Immunoreactivity to 6A7 was much higher after brief exposure (1-4 h) to TAT-His-WW-Pin1 but not after similar exposure to TAT-His-GFP or vehicle. In the absence of cytokine signaling, 6A7 reactivity spontaneously increased over 24 h, an effect that was accelerated by Pin1 inhibitors (Fig. 2f) . These results suggest that activation of Bax occurs by default in the absence of GM-CSF or IL-5 or when Pin1 is inhibited. In addition, these data show that Pin1 activity is needed to prevent exposure of the amino-terminal activation domain of Bax. Notably, treatment with juglone at a dose as low as 0.5 mM for 10 min resulted in activation of Bax, even in the presence of GM-CSF (Fig. 2g) . Thus, Pin1 interacts with and probably suppresses the activation of Bax in response to prosurvival cytokine signaling. Pin1 prevents translocation of Bax to mitochondria Activated Bax mediates cell death by translocating to and disrupting the mitochondrial outer membrane, leading to the release of cytochrome c and the caspase activator Smac 20 . To determine if Pin1 prevents Bax localization to and disruption of the mitochondria, we used immunofluorescence to track Bax localization in eosinophils after treatment with GM-CSF alone or together with Pin1 inhibitors. As populations of freshly isolated, unstimulated eosinophils contain cells at all stages of apoptosis, we did not image untreated eosinophils.
In the presence of GM-CSF alone, Bax staining was diffuse and cytosolic with occasional localization in mitochondria (Fig. 3a) . These findings are consistent with those presented above ( Fig. 2e ) and probably reflected a minor population of aged eosinophils that were irreversibly committed to apoptosis and expressed activated Bax 12 . Eosinophils treated with GM-CSF and TAT-His-WW-Pin1 had much more activated Bax that extensively overlapped mitochondria in most cells (Fig. 3a) . Quantification of several hundred eosinophils confirmed that the activation and mitochondrial localization of Bax were significantly greater after blockade of Pin1 (Fig. 3b) . Despite the localization of activated Bax together with mitochondria, these cells did not yet show morphological features of apoptosis, including changes in mitochondrial morphology, blebbing or nuclear condensation (data not shown), which indicated that Bax had yet to initiate 'downstream' caspase activation. Our data suggest that GM-CSF or IL-5, through Pin1, prevents Bax activation. In the absence of cytokines or in the presence of Pin1 inhibitors, Bax efficiently translocates to mitochondria in the absence of additional stimuli.
Cytokines induce phosphorylation of Bax
The cell cycle-dependent phosphorylation of antigens recognized by the antibody MPM-2 enhances the binding of Pin1 in tumor cells 28 . The finding that Pin1 interacted with Bax after cytokine treatment prompted us to assess whether cytokines induce the phosphorylation of Bax. For this, we left freshly purified eosinophils untreated or treated them with GM-CSF, then prepared lysates with nondenaturing detergents and analyzed them by immunoprecipitation with an antibody that recognizes activated as well as resting Bax proteins. GM-CSF induced phosphorylation of Bax on threonine but not serine residues (Fig. 4a) , which was blocked by inhibition of Pin1 (Fig. 4b) . Bax residues Ser163-Tyr164, Thr167-Pro168 and Ser184-Lys185 are phosphorylated in cancer cells by the kinase GSK3, the kinases Jnk and p38 (ref. 29) , and Akt 30 , respectively. Thr167-Pro168, a potential Pin1-recognition site, is probably critical in the activation of Bax by influencing carboxy-terminal and aminoterminal conformation 31 .
To determine if cytokine-induced phosphorylation of Bax Thr167 was required for the interaction of Bax with Pin1, we replaced Thr167 with alanine (T167A) and generated constructs of TAT fused to histidine-tagged, recombinant wild-type Bax (TAT-His-WT-Bax), T167A Bax (TAT-His-T167A-Bax) or GFP (TAT-His-GFP). We transduced eosinophils with equal amounts of TAT-His-WT-Bax, TAT-His-T167A-Bax or TAT-His-GFP 15 min after treating them with GM-CSF. We immunoprecipitated lysates with anti-Pin1, followed by immunoblot analysis with anti-histidine. TAT-His-WT-Bax precipitated together with endogenous Pin1, but TAT-His-T167A-Bax did not (Fig. 4c) . Consistent with the data presented above (Fig. 2b) , this interaction did not occur after blockade of Pin1 (data not shown). The small amount of T167A-Bax detected was probably nonspecific absorption to agarose beads during Pin1 immunoprecipitation. Of note, in experiments with Flag-tagged constructs, the transduced TAT-T167A-Bax had much less threonine phosphorylation than did TAT-WT-Bax (Fig. 4d) , which suggests that GM-CSF stimulation induces Thr167 phosphorylation.
It remained possible that Pin1 and Bax are part of a larger, macromolecular complex but do not directly interact. On the basis of the immunoblot results presented above (Fig. 4a-c) , we further hypothesized Pin1 and Bax would be more likely to interact when Bax was phosphorylated at Thr167. To test our hypothesis, we generated recombinant Flag-tagged versions of wild-type Bax and Bax mutants in which Thr167 was replaced with alanine (T167A) or glutamatic acid (T167E). The former mutant cannot be phosphorylated, whereas the latter mimics phosphorylated threonine. We incubated each Flagtagged Bax construct with glutathione S-transferase-Pin1 (GST-Pin1) in vitro in a cell-free assay. Small amounts of wild-type or T167A Bax bound to GST-Pin1, but there was much more GST-Pin1-bound T167E (Fig. 4e ). These data demonstrate that Pin1 and Bax directly interact and are more likely to do so if Thr167 is phosphorylated. The results presented above showed that Bax T167A mutants bound poorly to Pin1. If Pin1 binding is a 'prelude' to the formation of isomers, which prevents activation of Bax, Bax T167A mutants should block GM-CSF-mediated survival. To test that hypothesis, we transduced freshly isolated eosinophils with equal amounts of TAT-His-WT-Bax or TAT-His-T167A-Bax in the presence or absence of GM-CSF and assessed their survival and sensitivity to V5-mediated inhibition of Bax. TAT-His-WT-Bax had no effect on GM-CSFinduced survival at day 2, whereas TAT-His-T167A-Bax resulted in significantly lower survival than did TAT-His-WT-Bax (Fig. 4f) . At day 3, both TAT-His-WT-Bax and TAT-His-T167A-Bax resulted in significantly lower survival than that of untransduced control cells, but the T167A construct was significantly more 'deadly' (Fig. 4f) . We obtained similar results with IL-5-treated cells. Notably, the apoptosis of IL-5-treated cells induced by T167A was partially 'rescued' by V5 treatment (Fig. 4g) . These data collectively suggest that Bax Thr167 is phosphorylated in response to cytokine treatment and that phosphorylation of Thr167 facilitates the binding of Bax to Pin1. Such binding is essential for inhibiting the activation of Bax. In the absence of either phosphorylation of Bax Thr167 or interaction with Pin1, Bax is activated and orchestrates eosinophil death.
Erk1/2 interacts with and phosphorylates Bax
Many kinases have been linked to the regulation of Bax in diverse cellular systems. Akt protects tumor cells from apoptosis by phosphorylating Ser184 of Bax 32 , and Erk1/2 has also been linked to similar events 33 . PKC may also be involved in activating Bax, although the mechanism has not been established. As Akt, Erk1/2 and PKC are serine-threonine-directed kinases expressed by eosinophils 2,24 , we immunoprecipitated cell lysates from GM-CSF-treated cells with anti-Bax, followed by immunoblot analysis with antibodies specific for Akt, Erk1/2 or PKC. Bax reproducibly precipitated together with Erk1/2, but not with Akt or PKC (Fig. 5a) . We also sometimes noted interaction between Pim1 and Bax, which varied among samples from different donors (Fig. 5a and data not shown). Erk1/2 was associated with Bax in resting cells, in cells stimulated with GM-CSF and in cells treated with the MEK1 inhibitor PD98059 (Fig. 5b) . GM-CSF rapidly induced MEK1-dependent phosphorylation of Erk (Fig. 5c) and Bax (Fig. 5d) . In the absence of MEK1 activity, GM-CSF failed to induce the PPIase activity of Pin1 (Fig. 5e) . These results collectively indicate that Bax interacts with the proline-directed threonine-serine kinase Erk1/2, which, in response to cytokine signaling, phosphorylates Bax at Thr167. The data reported above also suggested that activation of Erk1/2 would be required for cytokine-induced eosinophil survival. Confirming that idea, we found that GM-CSF-induced survival was suppressed by the MEK1 inhibitors PD98059 and U0126 (Fig. 5f and data not shown). This impaired survival was reversed by treatment with the Bax inhibitor V5 (Fig. 5f and data not shown) .
Pin1 prevents cleavage of Bax by calpain
As Pin1 has over 1,000-fold more isomerase activity toward phosphorylated Thr-Pro than toward Thr-Pro bonds 28 , Bax proteins bearing phosphorylated Thr167 residues may be efficiently formed into isomers by Pin1. Such formation of isomers may prevent the cleavage of full-length Bax (p23) at Asp33 to p18, a modification that has been linked to mitochondrial targeting and proapoptotic activity of Bax 34 . Confirming that possibility, the large amounts of the p23 form of Bax detected in freshly isolated eosinophils decreased substantially within 24 h and were replaced by the p18 form of Bax (Fig. 6a,b) . Treatment with GM-CSF or IL-5, which promoted eosinophil viability, prevented the disappearance of p23 and appearance of p18 (Figs. 1a and 6a-c) . However, blockade of Pin1 antagonized the protective effects of GM-CSF and IL-5 and accelerated the cleavage (Fig. 6a,b) and activation (Figs. 2e,g and 3) of Bax.
Next we sought to identify the protease(s) responsible for cleaving Bax in this system. We focused on calpains, which are calciumdependent cysteine proteases and targets of Erk1/2 (refs. 34, 35) that have been linked to drug-induced death of tumor cells 34, 36 . Bax remained in its full-length form for 12 h in the presence or absence of GM-CSF (Fig. 6c) . However, blockade of Pin1 with juglone or TAT-WW-Pin1 induced cleavage of Bax within 12 h of GM-CSF treatment. This Bax cleavage was blocked by the calpain inhibitor calpeptin (Fig. 6c) but not by a proteasome inhibitor (Fig. 6a) . Cell death induced by Pin1 inhibitors was also partially suppressed by calpeptin and was completely suppressed by a broad-spectrum caspase inhibitor (Fig. 6d) .
On the basis of our results here, we propose the following model for Pin1-mediated regulation of Bax ( Supplementary Fig. 1 online) . In response to cytokine signaling, Pin1 is activated, whereas Bax is phosphorylated at Thr167 by Erk1/2. This phosphorylation enhances binding of Pin1 to, and probably the formation of isomers of, the phosphorylated Thr167-Pro168 peptide bond. This formation of isomers constrains Bax in an inactive conformation that is resistant to calpain-mediated cleavage. As eosinophils can survive for weeks in the asthmatic lung, this process can persist for extended periods of time. In the absence of cytokines or after loss of Pin1 function, Bax spontaneously exposes the 6A7 epitope and is cleaved at the amino terminus by calpain-like proteases. Both conformationally altered p23 Bax and cleaved p18 Bax translocate to mitochondoria, causing release of cytochrome c and activation of caspase-9 and caspase-3.
DISCUSSION
In this study we have identified a heretofore unknown function for Pin1 as a mediator of signaling by GM-CSF and IL-5 through direct regulation of Bax. Our results clarify how Bax function is regulated by cytokine signaling in terminally differentiated, growth factor-dependent eosinophils. They also suggest that Pin1 could be a new therapeutic target for the treatment of asthma as well as other eosinophilic diseases. Eosinophilic airway inflammation is a hallmark of asthma that often culminates in subepithelial fibrosis with variable airway obstruction. Drugs such as steroids that diminish the accumulation of eosinophils in the airways and parenchyma are the mainstay of therapy for asthmatics. A variety of monoclonal antibody-based therapies (anti-IL-5, anti-selectin and anti-chemokine receptor) 37 can block the development, trafficking and survival of eosinophils. Multiple doses of anti-IL-5 substantially deplete peripheral blood eosinophils but have modest effects on pulmonary eosinophils 38 . This may reflect both the loss of the IL-5 receptor b-subunit from pulmonary eosinophils 39 and persistently high expression of other antiapoptotic cytokines such as GM-CSF, which is induced by allergen exposure 22 . Pin1 is essential for the expression of GM-CSF 13, 40 , which along with IL-5 contributes to eosinophil survival in vitro. The data we have presented here suggest that blockade of Pin1 in vivo would not only decrease GM-CSF production 13, 40 but also activate the intrinsic apoptosis 'machinery' to accelerate eosinophil death.
Many pro-and antiapoptotic molecules are expressed by and associated with eosinophil death 25 . However, it has remained unclear how prosurvival cytokines attenuate eosinophil apoptosis. GM-CSF and IL-5 induce expression of Bcl-2 and Bcl-x L (ref. 10 ), but neither protein was detectable in eosinophils by immunoblot analysis even after treatment with IL-5 or GM-CSF (data not shown). Therefore, it is unlikely that the transcriptional induction of these proteins is of a sufficient magnitude or rapidity to account for the prolongation of survival by GM-CSF or IL-5. In contrast, freshly purified human eosinophils from every donor evaluated had high expression of Pin1 and Bax. After cell activation, Pin1 reproducibly interacted with Bax by a mechanism that was prevented by inhibition of the PPIase activity of Pin1. As Bax inhibition prevented cell death after withdrawal of GM-CSF or blockade of Pin1, Bax, rather than Bak and Bad, is the dominant proapoptotic multidomain Bcl-2 family protein responsible for orchestrating eosinophil death 25 . In support of that conclusion, allergen-challenged Bax-deficient mice accumulate nearly twofold more airway eosinophils after allergen challenge than do wild-type mice 41 . Similarly, there is less Bax in bronchial mucosal biopsies from patients with asthma 42 . These results suggest that the normal, rapid turnover of peripheral blood eosinophils probably reflects Bax activation in the absence of adequate prosurvival signaling or Pin1 activity.
Increasing evidence suggests that Pin1 is important in neuronal and tumor cell apoptosis 16 . Pin1 accelerates neuronal apoptosis by enhancing the expression and function of the proapoptotic Bcl-2 family member BimEL 19 . Moreover, Pin1 physically interacts with Bcl-2 in cancer cells arrested in M phase. Cell death is associated with more hyperphosphorylated Bcl-2 and p53, with the latter transactivating expression of the gene encoding Bax 17 . In contrast, in Alzheimer's disease, neuronal apoptosis is associated with the absence of Pin1 from the nucleus 18 . Those data and our data presented here suggest that Pin1 has a complex function in the apoptosis of dividing as well as quiescent, terminally differentiated cells. Unlike neurons, tumor cell lines and neutrophils, which all have abundant expression of several proteins of the Bcl-2 family [43] [44] [45] , eosinophils have high expression of Bax but very low expression of other pro-or antiapoptotic proteins of the Bcl-2 family 25 . Thus, eosinophils use an apparently less complex apoptotic signaling pathway. Whether Pin1 regulates other proapoptotic members of the Bcl-2 family has not been investigated. Our preliminary results showing interactions with cIAP2 and caspase-8 suggest that Pin1 may serve a broader function, perhaps in a cell typespecific way, in the overall regulation of apoptotic 'decisions' .
Despite the importance of Bax in apoptosis, the mechanisms that control the conformational modifications, activation and mitochondrial translocation of Bax are not completely understood. Ku70, which interacts with the amino terminus of Bax 26 , and humanin, which binds to the carboxyl terminus of Bax 46 , can both antagonize the activation of Bax. However, deficiency in Ku70 or humanin fails to induce translocation of Bax to mitochondria or apoptosis in the absence of appropriate stimuli. Mitochondria-associated Bax interacts with clusterin, which prevents the formation of Bax oligomers and release of cytochrome c 47 . In contrast, Pin1 selectively interacted with threoninephosphorylated Bax in cytokine-stimulated cells. In the absence of Pin1 interactions or PPIase activity, regardless of cytokine signaling, the 6A7 epitope became exposed and Bax translocated to the mitochondria. These data suggest that at least in cytokine-dependent primary human eosinophils, Bax is suppressed by Pin1, probably through the formation of isomers after Erk-mediated threonine phosphorylation.
Bax can be phosphorylated at three sites (Ser163-Tyr164, Thr167-Pro168 and Ser184-Lys185), which confers distinct phenotypes. Whereas phosphorylation of Ser163 induces cell death in neurons by promoting the translocation of Bax to mitochondria, phosphorylation of Ser184 reverses this phenotype 32 . Ser184-phosphorylated Bax can form heterodimers with the antiapoptotic molecules Mcl-1, Bcl-x L and A1 and thereby increase neutrophil survival 32 . Jnk-and p38-mediated phosphorylation of Thr167 accelerates the apoptosis of human tumor cells 29 , whereas Erk1/2 protects melanoma cells from apoptosis by inhibiting the release of Smac from mitochondria 33 . Thus, depending on the cell type, different MAPKs can modify Thr167 of Bax with disparate apoptotic endpoints.
Despite GM-CSF signaling, Bax was hypophosphorylated at Thr167 when Pin1 was inhibited. This result suggested that Pin1-mediated formation of isomers is required to stabilize phosphorylated Ser-Pro or Thr-Pro sites, possibly by preventing access of phosphatase to these sites. Consistent with that hypothesis, Pin1 interacts with and is itself regulated by the phosphatase PP2A 2 .
In primary human eosinophils, substitution of Bax Thr167 with alanine resulted in more Bax activity and less interaction with Pin1 and sensitivity to prosurvival signaling. Substitution of Bax Pro168 prevents the translocation of Bax to the mitochondria 31 . The Thr167-Pro168 site is located in a hinge immediately adjacent to the Bax carboxyterminal transmembrane domain. Our results suggest Pin1 forms isomers with phosphorylated Bax and that this constrains the carboxyl and amino termini in Bax. That idea is consistent with our inability to immunoprecipitate Bax with the active conformation-specific antibody 6A7 during prosurvival signaling. After cessation of cytokine signaling or blockade of the PPIase activity of Pin1, the amino-terminal domain of Bax is spontaneously exposed and Bax is activated.
Terminally differentiated eosinophils have high expression of the p23 form of Bax, which is cleaved to p18 during apoptosis or after Pin1 blockade. This process was completely blocked by GM-CSF, IL-5 and a calpain inhibitor. The p18 form of Bax is a more potent inducer of apoptosis than is the p23 form 37 . Cleavage of p23 occurred subsequent to exposure of the 6A7 epitope, approximately 12 h after cytokine withdrawal. Similar events occur in tumor cell lines treated with chemotherapeutic agents 36 . The toxicity of the p18 form of Bax may reflect exposure of the hydrophobic Bcl-2 homology 3 domain (amino acids 59-73), which facilitates the formation of oligomers and death pores in the mitochondrial outer membrane 48 . Consistent with those results, the p18 form of Bax is detected exclusively in the mitochondrial fraction and is associated with more activation of calpain. A plausible hypothesis is that Pin1 maintains Bax in a calpain-resistant conformation, thereby diminishing the generation of p18.
